DRIO
DarioHealth Corp.NASDAQHealthcare$8.40+3.70%ClosedMarket Cap: $61.3M
As of 2026-04-06
Valuation
P/E (TTM)
6.75
PEG
0.00
P/B
6.14
P/S
2.74
EV/EBITDA
-1.82
DCF Value
$-5.99
FCF Yield
-42.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
56.6%
Operating Margin
-163.9%
Net Margin
276.1%
ROE
88.0%
ROA
168.1%
ROIC
-36.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $5.2M | 45.3% | $-45.8M | $86.0M | $1.90 | — |
| FY 2025 | $22.4M | 56.6% | $-36.7M | $-41.7M | $1.24 | — |
| Q3 2025 | $5.0M | 60.2% | $-9.5M | $-2.1M | $0.38 | — |
| Q2 2025 | $5.4M | 63.3% | $9.2M | $-13.0M | $-0.20 | — |
| Q1 2025 | $6.8M | 57.5% | $9.4M | $-9.2M | $0.14 | — |
| Q4 2024 | $7.6M | 72.2% | $11.7M | $-9.6M | $-0.26 | — |
| FY 2024 | $27.0M | 49.1% | $-57.7M | $-42.7M | $-0.74 | — |
| Q3 2024 | $7.4M | 70.3% | $12.0M | $-12.3M | $0.36 | — |
| Q2 2024 | $6.3M | 63.8% | $16.2M | $-13.6M | $-0.08 | — |
| Q1 2024 | $5.8M | 42.2% | $17.9M | $-7.2M | $-0.20 | — |
| Q4 2023 | $3.6M | 34.2% | $14.2M | $-14.3M | $-0.44 | — |
| FY 2023 | $20.4M | 29.4% | $-56.2M | $-59.4M | $-1.93 | — |